Drug shortage: Liraglutide Injection (VICTOZA, SAXENDA, LIRAGLUTIDE)
FDA lists 11 presentations as Current. Availability: Limited Availability (3), Available (6). Reason: Delay in shipping of the drug; Discontinuation of the manufacture of the drug. Companies: Novo Nordisk, Inc., Teva Pharmaceuticals USA, Inc., Hikma Pharmaceuticals USA, Inc., Meitheal Pharmaceuticals, Inc..
- Published by source
- 2023-07-18
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-30
Affected
- Manufacturer
- Novo Nordisk, Inc.
- Products
- Liraglutide Injection VICTOZA SAXENDA LIRAGLUTIDE
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Limited Availability
Remedy / actions:
- Estimated shortage duration: TBD
- Product will be available until discontinuation in January 2027
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2023-07-18
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #903 | new | 2026-10-22 | b158195b99af…2351e4 | 748f6514da15…9470a9 |
| #1151 | update | 2026-10-23 | 7f4df0729f2f…7f2792 | 41e4edd9257a…2ef1e7 |
| #1355 | update | 2026-10-23 | 9e54f1fa72e2…7093b9 | 1e463f7c3b58…baa8f7 |
| #2174 | update | 2026-10-27 | 48a0f378bd9c…1a7f32 | 2f5e57b20fbf…efeb93 |
| #2415 | update | 2026-10-27 | 7b946f1173ca…ae6131 | 449714297de2…0da7bc |
| #2549 | update | 2026-10-28 | 4f076f10df14…205ccc | a41fbed0c10a…c53249 |
| #2713 | update | 2026-10-28 | 72d0881d9afe…fd62a1 | 4294b8bd2d5e…808bcb |
| #2840 | update | 2026-10-29 | 6cd5209748e3…349151 | 49d0aae41df6…ae6e37 |
| #3087 | update | 2026-10-30 | 277850dcfaaa…a60971 | 948d983ec592…dd4d62 |
Chain head: #3174 cbfa23d88c9b…201fc3